25 July 2024 false No description of principal activity Taxfiler 2024.6 10571823 business:PrivateLimitedCompanyLtd 2024-07-25 2025-07-24 10571823 2024-07-24 10571823 2024-07-25 2025-07-24 10571823 business:AuditExempt-NoAccountantsReport 2024-07-25 2025-07-24 10571823 business:AbridgedAccounts 2024-07-25 2025-07-24 10571823 2025-07-24 10571823 business:Director1 2024-07-25 2025-07-24 10571823 business:RegisteredOffice 2024-07-25 2025-07-24 10571823 2024-07-24 10571823 core:WithinOneYear 2025-07-24 10571823 core:WithinOneYear 2024-07-24 10571823 core:AfterOneYear 2025-07-24 10571823 core:AfterOneYear 2024-07-24 10571823 core:ShareCapital core:PreviouslyStatedAmount 2025-07-24 10571823 core:ShareCapital core:PreviouslyStatedAmount 2024-07-24 10571823 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-07-24 10571823 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-07-24 10571823 core:PreviouslyStatedAmount 2025-07-24 10571823 core:PreviouslyStatedAmount 2024-07-24 10571823 business:SmallEntities 2024-07-25 2025-07-24 10571823 countries:EnglandWales 2024-07-25 2025-07-24 10571823 core:MotorVehicles 2024-07-25 2025-07-24 10571823 core:FurnitureFittings 2024-07-25 2025-07-24 10571823 core:ComputerEquipment 2024-07-25 2025-07-24 10571823 2023-07-25 2024-07-24 iso4217:GBP xbrli:pure
Company Registration No. 10571823 (England and Wales)
TRAFALGAR PHARMA LTD Unaudited accounts for the year ended 24 July 2025
TRAFALGAR PHARMA LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
TRAFALGAR PHARMA LTD Company Information for the year ended 24 July 2025
Director
Rui Guo
Company Number
10571823 (England and Wales)
Registered Office
143 Pools Brook Park Kingswood Hull HU7 3GF United Kingdom
- 3 -
TRAFALGAR PHARMA LTD Statement of financial position as at 24 July 2025
2025
2024
Notes
£
£
Fixed assets
Intangible assets
4
37
62
Tangible assets
5
152
329
189
391
Current assets
Debtors
8,996
9,710
Cash at bank and in hand
2,531
3,784
11,527
13,494
Creditors: amounts falling due within one year
(600)
(600)
Net current assets
10,927
12,894
Total assets less current liabilities
11,116
13,285
Creditors: amounts falling due after more than one year
(65,672)
(65,672)
Net liabilities
(54,556)
(52,387)
Capital and reserves
Called up share capital
100
100
Profit and loss account
(54,656)
(52,487)
Shareholders' funds
(54,556)
(52,387)
For the year ending 24 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 April 2026 and were signed on its behalf by
Rui Guo Director Company Registration No. 10571823
- 4 -
TRAFALGAR PHARMA LTD Notes to the Accounts for the year ended 24 July 2025
1
Statutory information
TRAFALGAR PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 10571823. The registered office is 143 Pools Brook Park, Kingswood, Hull, HU7 3GF, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
- 25% on straight line basis
Fixtures & fittings
- 15% on cost
Computer equipment
- 33% on cost
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total
£
Cost
At 25 July 2024
187
At 24 July 2025
187
Amortisation
At 25 July 2024
125
Charge for the year
25
At 24 July 2025
150
Net book value
At 24 July 2025
37
At 24 July 2024
62
- 5 -
TRAFALGAR PHARMA LTD Notes to the Accounts for the year ended 24 July 2025
5
Tangible fixed assets
Total
£
Cost or valuation
At 25 July 2024
15,247
At 24 July 2025
15,247
Depreciation
At 25 July 2024
14,918
Charge for the year
177
At 24 July 2025
15,095
Net book value
At 24 July 2025
152
At 24 July 2024
329
6
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -